We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
AUM
$2.8B
AUM Growth
+$499M
Cap. Flow
+$405M
Cap. Flow %
14.45%
Top 10 Hldgs %
31.47%
Holding
745
New
93
Increased
296
Reduced
180
Closed
64

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$8.56M
2
CELG
Celgene Corp
CELG
+$6.53M
3
SNA icon
Snap-on
SNA
+$5.49M
4
AMG icon
Affiliated Managers Group
AMG
+$4.97M
5
MAR icon
Marriott International
MAR
+$3.57M

Sector Composition

Rank Sector Weight
1 Technology 18.14%
2 Healthcare 14.73%
3 Financials 11.88%
4 Consumer Discretionary 10.78%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDDY icon
651
GoDaddy
GDDY
$11.5B
$66K ﹤0.01%
933
LNT icon
652
Alliant Energy
LNT
$18B
$65K ﹤0.01%
1,313
REG icon
653
Regency Centers
REG
$14.1B
$65K ﹤0.01%
974
WVE icon
654
Wave Life Sciences
WVE
$1.2B
$65K ﹤0.01%
2,475
+474
+24% +$13.3K
ECOM
655
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$63K ﹤0.01%
7,248
REPL icon
656
Replimune Group
REPL
$1.01B
$61K ﹤0.01%
4,156
COTY icon
657
Coty
COTY
$2.48B
$58K ﹤0.01%
4,359
ALC icon
658
Alcon
ALC
$35B
$57K ﹤0.01%
+910
New +$53.4K
MAA icon
659
Mid-America Apartment Communities
MAA
$15.7B
$57K ﹤0.01%
485
CBAY
660
DELISTED
Cymabay Therapeutics
CBAY
$57K ﹤0.01%
7,948
KALV
661
DELISTED
KalVista Pharmaceuticals
KALV
$56K ﹤0.01%
2,512
RH icon
662
RH
RH
$3.71B
$56K ﹤0.01%
+487
New +$50.2K
AKRO
663
DELISTED
Akero Therapeutics
AKRO
$54K ﹤0.01%
+2,800
New +$53.1K
ESTC icon
664
Elastic
ESTC
$7.81B
$54K ﹤0.01%
721
-1,500
-68% -$122K
AIV
665
Aimco
AIV
$383M
$49K ﹤0.01%
7,342
CYCN icon
666
Cyclerion Therapeutics
CYCN
$16.7M
$48K ﹤0.01%
+210
New +$59.4K
NTNX icon
667
Nutanix
NTNX
$16.9B
$47K ﹤0.01%
1,808
-3,736
-67% -$130K
HRB icon
668
H&R Block
HRB
$5.86B
$46K ﹤0.01%
+1,565
New +$42.1K
AQST icon
669
Aquestive Therapeutics
AQST
$494M
$45K ﹤0.01%
10,742
SLG icon
670
SL Green Realty
SLG
$3.99B
$44K ﹤0.01%
557
CHMA
671
DELISTED
Chiasma, Inc. Common Stock
CHMA
$39K ﹤0.01%
5,230
+530
+11% +$3.48K
TRIP icon
672
TripAdvisor
TRIP
$1.26B
$38K ﹤0.01%
824
-37
-4% -$1.8K
KIM icon
673
Kimco Realty
KIM
$16.4B
$32K ﹤0.01%
1,716
BPY
674
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$31K ﹤0.01%
1,656
CRNX icon
675
Crinetics Pharmaceuticals
CRNX
$8.92B
$30K ﹤0.01%
1,208

Similar funds

Tiverton Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Tiverton Asset Management held 745 positions worth $2.8B, up 22% from $2.31B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tiverton Asset Management deployed $405M of net new capital in Q2 2019, opening 93 new positions and adding to 296 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 3,684,172 shares worth $145M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $6.53M trimmed.

  • Tiverton Asset Management's largest Q2 2019 buy was iShares Russell 1000 Growth ETF: 3,684,172 shares worth $145M.
  • Tiverton Asset Management added most to Air Products & Chemicals in Q2 2019, an estimated $12.7M increase.
  • Tiverton Asset Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $6.53M.
  • Tiverton Asset Management fully exited Linde in Q2 2019, selling an estimated $8.56M.
  • Tiverton Asset Management's ten largest holdings make up 31% of its $2.8B portfolio in Q2 2019.
  • Tiverton Asset Management opened 93 new positions and closed 64 in Q2 2019.
  • Tiverton Asset Management's portfolio value rose 22% quarter-over-quarter to $2.8B.

Based on Tiverton Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.